Canadian pharmaceutical giant, Valeant, acquires global eye health company, Bausch and Lomb for $8.7 billion
Valeant Pharmaceuticals International, Inc. and Bausch + Lomb Holdings Incorporated, the global eye health company, today announced that they have entered into a definitive agreement under which Valeant will acquire More...